Local view for "http://purl.org/linkedpolitics/eu/plenary/2004-04-21-Speech-3-194"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20040421.8.3-194"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
".
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has done an extremely good job of improving knowledge of drugs and drug addiction, by providing comparable data and information and primarily by monitoring and identifying dangerous substances that appear on the market and by proposing that these should be banned.
It makes sense that, for reasons of clarity and openness, the Regulation establishing the EMCDDA should be recast, particularly in order to adapt it to the enlargement of the EU and to broaden its mandate to cover polydrug use, involving both legal and illegal substances.
I cannot, however, accept the attempt to confer evaluation tasks on the EMCDDA. The intention is that the Monitoring Centre should not simply collect data but should also evaluate national policies and strategies and assess trends in drug consumption. This would confer on an agency powers that are currently held by the Member States.
The Monitoring Centre should be entrusted with the task of furnishing overall information, in other words, of collecting, analysing and disseminating data on all aspects of the phenomenon of drugs and drug addiction, which will help to provide the Community and its Member States with an overall view of the drug and drug addiction phenomenon. This task should not prejudice the allocation of powers between the Community and its Member States with regard to the legislative provisions concerning drug supply and demand."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples